Last reviewed · How we verify
Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition (EGTCLINIC)
This trial employed a non-randomized, double-blind, placebo-controlled design to evaluate the effects of DR. ERGO® Capsules (each containing 30mg of ergothioneine) on the skin condition of women aged 35 to 59 after continuous daily intake for 8 weeks. The trial assessed skin condition across multiple dimensions, including brightness, color tone, melanin, erythema, gloss, elasticity, and spots, using various instruments and questionnaire surveys. Additionally, safety was monitored through daily log records and safety evaluations.
Details
| Lead sponsor | Shanghai EGT Synbio Group Co., Ltd. |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 70 |
| Start date | Wed Oct 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Skin
Interventions
- The capsules contain Ergothioneine.
- The capsules do not contain Ergothioneine.
Countries
Japan